Bank Of America Corp Fibrogen Inc Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Fibrogen Inc stock. As of the latest transaction made, Bank Of America Corp holds 160,882 shares of FGEN stock, worth $51,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160,882

Previous 216,943 25.84%

Holding current value

$51,482

Previous $509,000 71.91%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.89 - $2.36 $49,894 - $132,303	-56,061 Reduced 25.84%	160,882 $143,000
Q1 2024 May 15, 2024	SELL	$0.73 - $2.73 $34,699 - $129,767	-47,534 Reduced 17.97%	216,943 $509,000
Q4 2023 Feb 14, 2024	SELL	$0.38 - $0.91 $101,050 - $241,989	-265,922 Reduced 50.14%	264,477 $235,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $347,300 - $2.87 Million	139,478 Added 35.68%	530,399 $1.43 Million
Q1 2023 May 12, 2023	BUY	$15.95 - $25.18 $709,535 - $1.12 Million	44,485 Added 12.84%	390,921 $7.29 Million
Q4 2022 Feb 10, 2023	BUY	$13.27 - $17.73 $1.89 Million - $2.52 Million	142,363 Added 69.76%	346,436 $5.55 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $884,400 - $1.13 Million	77,579 Added 61.33%	204,073 $2.65 Million
Q2 2022 Aug 12, 2022	SELL	$7.94 - $12.96 $2.05 Million - $3.34 Million	-257,585 Reduced 67.07%	126,494 $1.34 Million
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $2.09 Million - $2.93 Million	174,242 Added 83.04%	384,079 $4.62 Million
Q4 2021 Feb 08, 2022	BUY	$9.93 - $15.39 $1.4 Million - $2.17 Million	140,983 Added 204.76%	209,837 $2.96 Million
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $373,524 - $977,474	-36,692 Reduced 34.76%	68,854 $704,000
Q2 2021 Sep 13, 2021	BUY	$18.57 - $35.68 $1.96 Million - $3.77 Million	105,546 New	105,546 $2.81 Million

Others Institutions Holding FGEN

# of Institutions

110

Shares Held

55.5M

Call Options Held

2.14M

Put Options Held

1.42M

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $30M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Fibrogen Inc Transaction History